Related Experiment Video

Updated: Mar 20, 2026

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
13:59

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on: August 18, 2023

2.9K

Economic Impact of Using Subcutaneous Trastuzumab

F Gutierrez1, G Nazco1, M Viña2

  • 1University Hospital of Canary Islands, La Laguna, Spain.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|May 21, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.1K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.7K

Related Experiment Videos

Last Updated: Mar 20, 2026

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
13:59

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on: August 18, 2023

2.9K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.1K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K

Articles linked to this work by shared authors, journal, and citation graph.

Human papillomavirus 68 subtypes among people with human immunodeficiency virus and implications for anal screening.

Communications medicine·2026

Therapeutic Apheresis Registry of the Spanish Society of Nephrology. Analysis of activity over the last five years.

Nefrologia·2026

Optimising Transitions of Care and Long-Term Management in Heart Failure: A Scoping Review of Strategies and Models.

ESC heart failure·2026

Microbial Community Metagenomics in the Eastern Tropical North Pacific Oxygen Minimum Zone Reveals Functional Differences Along Biogeochemical Gradients.

Environmental microbiology·2026

Automatic Pipeline for Kinematic Tracking of Clinically Relevant Upper-Limb Motor Tasks in Humans and Macaque.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025

Beyond biomass production: Enhancing biodiversity while capturing carbon in short rotation coppice poplar plantations.

The Science of the total environment·2024

Cost-Effectiveness of Epigenetic Drugs in Oncology: A Systematic Review of Economic Evaluations.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Measuring cause-specific tolerance for health inequalities using the social marginal rate of substitution.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Reasons for distributional preferences for health outcomes: A mixed method interview study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Swimming in the Sea of Real-World Evidence (RWE) Guidance: Why More Guidance Documents Are Needed to Help Researchers Swim.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Reframing NICE's Cost-Effectiveness Threshold: Technical Benchmark or Policy Signal? A Documentary Content Analysis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Economic evaluations of hypertension interventions in pregnancy lack standardisation: results of a systematic review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Hypertrophic Cardiomyopathy Mimicking Cardiac Involvement on 18F-FDG PET/CT in a Patient With Lymphoma.

Clinical nuclear medicine·2026

pH-Responsive liposomes co-delivering a membrane-active peptide and the PI3Kγ inhibitor to reconstruct the tumor microenvironment for enhanced antitumor immunotherapy.

Biomaterials science·2026

Performance of a high-sensitivity troponin-based early rule-out pathway for suspected myocardial infarction.

Acta cardiologica·2026

Percutaneous Suction Drain Versus Conventional Incision and Drainage for the Management of Acute Breast Abscess: A Prospective Comparative Study.

Cureus·2026

The combination of alternating reduced-dose blinatumomab and hyper-CVAD as consolidation therapy in patients with newly-diagnosed adult B-cell acute lymphoblastic leukemia.

Therapeutic advances in hematology·2026

Immune Checkpoint Inhibitor-Related Gastrointestinal Toxicity: Pathogenesis, Diagnosis, and Management.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us